D. Byrd

1.3k citations
6 papers · 1k · 1 hit paper · h-index 4

Impact in

  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

D. Byrd

5 papers receiving 1k citations

D. Byrd's Hit Papers

Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells 2002 · 993 citations
9930+8+16Years since publication250500750

Peers

D. Byrd
Comparison fields: 5 of 48
  • Immunology 723
  • Oncology 463
  • Microbiology 3
  • Genetics 22
  • Virology 11
Replace Eunseon Ahn with:
Eunseon Ahn United States
Nick J. Pumphrey United States
Christina Claus Switzerland
Valentina Casella Spain
Fernanda Castro United Kingdom
Patrice Y. Neese United States
Annelies Jorritsma Netherlands
Leila Mekkaoui United Kingdom
Camillia S. Azimi United States
Jack P. Higgins United States
D. Byrd relative to Eunseon Ahn United States Eunseon Ahn's profile →
Citations per field
00.5×2×4×6×7.8×
Eunseon Ahn · 1×
Citations per year

Countries citing papers authored by D. Byrd

Since Specialization
Citations

This map shows the geographic impact of D. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Byrd more than expected).

Fields of papers citing papers by D. Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Byrd. The network helps show where D. Byrd may publish in the future.

Co-authors

The 17 scholars most cited alongside D. Byrd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Byrd Line = papers co-authored together D. Byrd links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells
Hit paper breakdown →
2002993
2 200135
3 201511
4 19995
5 19983
6 20230

About D. Byrd

D. Byrd is a scholar working on Immunology, Biotechnology, Pharmacology, Public Health, Environmental and Occupational Health and Oncology, having authored 6 papers that have together received 1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Innovations in Medical Education (2 papers), Fungal Infections and Studies (1 paper), Microbial Inactivation Methods (1 paper), Polyomavirus and related diseases (1 paper), Pharmacy and Medical Practices (1 paper) and Hydraulic Fracturing and Reservoir Analysis (1 paper). The work is most often cited by research in Immunology (723 citations), Oncology (463 citations), Microbiology (3 citations), Genetics (22 citations) and Virology (11 citations). D. Byrd has collaborated with scholars based in United States. Frequent co-authors include Patrick C. Roche, Esteban Celis, Philip D. Greenberg, Cassian Yee, Stanley R. Riddell, John A. Thompson, Rokea A. el‐Azhary, Shailender Bhatia, Jayasri G. Iyer and Richard F. Heller. Their work appears in journals such as Academic Medicine, European Journal of Cancer, Journal of the European Academy of Dermatology and Venereology, Proceedings of the National Academy of Sciences and Southern Medical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact